An Efficacy and Safety Study Of Pracinostat In Combination With Azacitidine In Adults With Acute Myeloid Leukemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
138 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital Italiano de Buenos Aires
Ciudad Autonoma de Buenos Aire, Buenos Aires, Argentina
- Instituto Medico Especializado Alexander Fleming
Ciudad Autonoma de Buenos Aire, Buenos Aires, Argentina
- Hospital Italiano la Plata
La Plata, Buenos Aires, Argentina
- Sanatorio Britanico Sa Paraguay 40, 3p
Rosario, Santa Fe Province, Argentina
- H Ospi Tal Privado de Cordoba
Córdoba, Argentina
- Sanatorio Allende
Córdoba, Argentina
- Liverpool Hospital
Liverpool, New South Wales, Australia
- Sunshine Coast University Hospital
Birtinya, Queensland, Australia
- Royal Hobart Hospital
Hobart, Tasmania, Australia
- the Northern Hospital Pharmacy Department, Ground Floor
Epping, Victoria, Australia
- Barwon Health, University Hospital Geelong
Geelong, Victoria, Australia
- Austin Hospital, Clinical Trial Pharmacy
Heidelberg, Victoria, Australia
- Liverpool Hospital
Liverpool, Australia
- Royal Perth Hospital
Perth, Australia
- Prince of Wales Hospital
Randwick, Australia
- Krankenhaus Der Elisabethinen Linz Gmbh
Linz, Austria
- Müllner Hauptstrabe 48
Salzburg, Austria
- General Hospital Hietzing
Vienna, Austria
- Liga Paranaense de Com Bate Ao Cancer - Hospital Erasto Gaertner
Curitiba, Paraná, Brazil
- Ce Ntro de Pesquisas Hospital Amara L Ca Rvalh O
Jaú, São Paulo, Brazil
- Centro de Pesquisa Clinica Do Hospital Santa Marcelina
São Paulo, São Paulo, Brazil
- Hospital de Cancer de Barretos
Barretos, Brazil
- Hospital Santa Casa de Belo Horizonte -Serviyo de Oncologia Clinica
Belo Horizonte, Brazil
- Centro de Pesquisas Oncologicas - Cepon
Florianópolis, Brazil
- Hospital de Clã-Nicas de Porto Alegre
Porto Alegre, Brazil
- Institute Nacional de Cancer Jose de Alencar Gomes Da Silva-Inca
Rio de Janeiro, Brazil
- Faculdade de Medicina Do Abc - Centro de Estudos E Pesquisas de Hematologia E Oncologia
Santo André, Brazil
- Hospital de Base de Sao Jose Do Rio Preto
São José do Rio Preto, Brazil
- "fakultni Nemocnice Hradec Kralove,
Hradec Králové, Czechia
- Fakultni Nemocnice Olomuc
Olomouc, Czechia
- "fakultni Nemocnice Kralovske Vinohrady,
Prague, Czechia
- Fakultni Nemocnice Kralovske Vinohrady,
Prague, Czechia
- Vseobecna Fakultni Nemocnice
Prague, Czechia
- Chu Amiens Picardie-Site Sud-Service D'Hematologie
Amiens, France
- L'Hopital Privé Du Confluent Sas
Nantes, France
- Chu de Nice, Archet 1 Hospital-Hematology Department
Nice, France
- Hospital Saints Louis
Paris, France
- Haut-Leveque-Service D'Hématologie Clinique Et de Thérapie Cellular
Pessac, France
- Centre Hospitalier Lyon Sud
Pierre-Bénite, France
- Centre Henri Becquerel
Rouen, France
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Jun 2017
- Primary completion
- 20 Aug 2020
- Completion
- 20 Aug 2020
- Last update posted
- 10 Mar 2022
- Registered enrollment
- 406
- Registry id
- NCT03151408
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.